Technology
Laser microporation
Drug delivery
Applications
Publications
PharmaTelevision Interview with Christof Böhler
Products & Services
P.L.E.A.S.E.
®
Devices
Aesthetic dermatology
Medical solutions
Transdermal delivery
Intradermal delivery
Epidermal delivery
Infertility patches
Pipeline
Centres of Excellence
Partnering
Investors
About us
Company
The Big Picture
History
Management Team
Board
Advisory Board
Career Opportunities
Contact
General terms and conditions
Events & News
Conferences
Press releases
Press Articles
« back
Archive
Pantec Biosolutions reports first successful IVF pregnancy using P.L.E.A.S.E.
®
-FSH patch
Pantec Biosolutions Achieves Clinical Efficacy POC for Delivery of urinary FSH using P.L.E.A.S.E.
®
Pantec Biosolutions to exhibit MEDICA 2010 World Forum in Düsseldorf, Germany on 17-20 November 2010
Pantec Biosolutions receives "Honourable Mention" in red dot awards
Pantec Biosolutions Closes CHF 20 Million Financing
Pantec Biosolutions' P.L.E.A.S.E. Professional
®
Receives Marketing Authorisation
Pantec Biosolutions reports successful Phase I for delivery of FSH using P.L.E.A.S.E.
®
Pantec Biosolutions is Granted SME Status in EU
Pantec Biosolutions Granted European Patent for P.L.E.A.S.E.
®
Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E.
®
technology
Pantec Biosolutions Expands Scientific Advisory Board
Pantec Biosolutions Receives Marketing Clearance for P.L.E.A.S.E.
®
Pantec Biosolutions receives ISO 13485 certification
Pantec Biosolutions appoints new Board members
Pantec Biosolutions unveils preclinical data for novel transdermal drug delivery platform
Pantec Biosolutions presented new drug delivery platform and supporting preclinical data at Drug Delivery Partnerships 2008
Pantec Biosolutions successfully initiates Series A Financing Round
New web animation showing how the P.L.E.A.S.E.
®
platform works
Nomination for Swiss Medtech Award 2007
Human cutaneous tolerability study concluded positively
